Dr. Adriana Rossi works with faculty members in Hematological Malignancies to develop sponsored clinical and translational research activities pertaining to the detection of minimal residual disease. Her research is further focused on novel approaches for patients with relapsed and refractory myeloma including new drug development.
Dr. Rossi is the Principal Investigator on a KL2 Post-Doctoral Scholars Award through 2014, and Co-investigator on an award from the Leukemia and Lymphoma Society (PI Niesvizky) through 2015. In addition to publishing several abstracts, she has published four articles in prestigious peer reviewed journals including a first-authored article published in Blood.
Dr. Rossi is a journal reviewer for Leukemia and Lymphoma, Therapeutic Advances in Hematology, and Blood. In addition to three Grand Rounds, her invited presentations include talks at ASCO, the American Cancer Society Schilling Conference, and Biomedical Sciences retreat.